161 related articles for article (PubMed ID: 29369808)
41. Anticentromere antibody specific to human cells directed against the CENP-B autoantigen.
Bejarano LA; Bolivar J; Valdivia MM
Cytogenet Cell Genet; 1993; 63(1):54-8. PubMed ID: 7680607
[TBL] [Abstract][Full Text] [Related]
42. Brief Report: Anti-Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis.
Betteridge ZE; Woodhead F; Lu H; Shaddick G; Bunn CC; Denton CP; Abraham DJ; du Bois RM; Lewis M; Wells AU; McHugh NJ
Arthritis Rheumatol; 2016 Nov; 68(11):2778-2783. PubMed ID: 27273608
[TBL] [Abstract][Full Text] [Related]
43. Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.
Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Wang M; Baron M; Fritzler MJ; ; ;
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S131-5. PubMed ID: 26315678
[TBL] [Abstract][Full Text] [Related]
44. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
[TBL] [Abstract][Full Text] [Related]
45. Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis.
Yamakawa H; Hagiwara E; Kitamura H; Yamanaka Y; Ikeda S; Sekine A; Baba T; Iso S; Okudela K; Iwasawa T; Takemura T; Kuwano K; Ogura T
PLoS One; 2016; 11(8):e0161908. PubMed ID: 27564852
[TBL] [Abstract][Full Text] [Related]
46. Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis.
Johnson ME; Grassetti AV; Taroni JN; Lyons SM; Schweppe D; Gordon JK; Spiera RF; Lafyatis R; Anderson PJ; Gerber SA; Whitfield ML
Arthritis Res Ther; 2016 Jan; 18():27. PubMed ID: 26801089
[TBL] [Abstract][Full Text] [Related]
47. Clinical associations of anti-CENP-B and anti-Scl70 antibody levels measured by multiplexed fluorescent microsphere immunoassay in systemic sclerosis.
Volpe A; Ruzzenente O; Caramaschi P; Pieropan S; Tinazzi I; Carletto A; Bambara LM; Biasi D
Rheumatol Int; 2009 Jul; 29(9):1073-9. PubMed ID: 19194705
[TBL] [Abstract][Full Text] [Related]
48. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
49. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
[TBL] [Abstract][Full Text] [Related]
50. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
[TBL] [Abstract][Full Text] [Related]
51. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
Kuwana M; Kaburaki J; Medsger TA; Wright TM
Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
[TBL] [Abstract][Full Text] [Related]
52. Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement.
Generini S; Steiner G; Miniati I; Conforti ML; Guiducci S; Skriner K; Kaloudi O; Giacomelli R; Smolen J; Matucci-Cerinic M
Rheumatology (Oxford); 2009 Aug; 48(8):920-5. PubMed ID: 19483090
[TBL] [Abstract][Full Text] [Related]
53. Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.
Markusse IM; Meijs J; de Boer B; Bakker JA; Schippers HPC; Schouffoer AA; Ajmone Marsan N; Kroft LJM; Ninaber MK; Huizinga TWJ; de Vries-Bouwstra JK
Rheumatology (Oxford); 2017 Jul; 56(7):1081-1088. PubMed ID: 27940596
[TBL] [Abstract][Full Text] [Related]
54. Serologic abnormalities in systemic sclerosis.
Harvey GR; McHugh NJ
Curr Opin Rheumatol; 1999 Nov; 11(6):495-502. PubMed ID: 10551674
[TBL] [Abstract][Full Text] [Related]
55. Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated Scleroderma.
Shah AA; Xu G; Rosen A; Hummers LK; Wigley FM; Elledge SJ; Casciola-Rosen L
Arthritis Rheumatol; 2017 Jun; 69(6):1306-1312. PubMed ID: 28217959
[TBL] [Abstract][Full Text] [Related]
56. Combining multi-antigenic immunodot with indirect immunofluorescence on HEp-2 cells improves the diagnosis of systemic sclerosis.
Bost C; Fortenfant F; Blancher A; Pugnet G; Renaudineau Y
Clin Immunol; 2021 Aug; 229():108774. PubMed ID: 34111525
[TBL] [Abstract][Full Text] [Related]
57. Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss.
Schachna L; Wigley FM; Morris S; Gelber AC; Rosen A; Casciola-Rosen L
Arthritis Rheum; 2002 Jul; 46(7):1873-84. PubMed ID: 12124872
[TBL] [Abstract][Full Text] [Related]
58. The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3).
Perosa F; Vicenti C; Racanelli V; Leone P; Valentini G; Dammacco F
Clin Immunol; 2010 Oct; 137(1):60-73. PubMed ID: 20630806
[TBL] [Abstract][Full Text] [Related]
59. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
Coelho Horimoto AM; da Costa IP
Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
[TBL] [Abstract][Full Text] [Related]
60. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
